
Includes adenocarcinoma, squamous cell carcinoma, and small-cell lung cancer lines.

Covers hormone receptor–positive, triple-negative, HER2+ breast cancer models.

Features adenocarcinoma, metastatic variants, and chemotherapy-resistant strains.

Includes ductal adenocarcinoma and resistant pancreatic tumor cell lines.

ALL, AML, CML, multiple myeloma, Hodgkin’s, non-Hodgkin’s lymphoma.

Squamous cell carcinoma and adenocarcinoma lines.

Models for endocrine and gynecological cancers.

Hard-to-find lines (e.g., lingual carcinoma, rare hematological malignancies).
Your cart is empty Continue Shopping